Clinical Trials Logo

Clinical Trial Summary

This is a prospective, randomized, double-blind, placebo-controlled study about the effect of metformin in patients with mild Graves' ophthalmopathy. Eighty patients with mild ophthalmopathy will be included. Each patient will be given either metformin (500mg PO three times a day) or placebo ( PO three times a day ) for 6 months and then followed for 6 months after withdrawal of treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02535975
Study type Interventional
Source Yonsei University
Contact Eun Jig Lee, MD, PhD
Phone +82-2-2228-1983
Email ejlee432@yuhs.ac
Status Recruiting
Phase N/A
Start date December 2014
Completion date October 2019